Greg Pyszczymuka, Chief Commercial Officer at AYTU BIOPHARMA, INC (AYTU), bought 100,000 shares at $0.24 ($24K) on 2022-12-19, disclosed to the SEC on 2022-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.